Gastroenterology

Gastroenterology

Volume 140, Issue 7, June 2011, Pages 2107-2115.e4
Gastroenterology

Basic—Liver, Pancreas, and Biliary Tract
Genetic and Pharmacologic Inhibition of the Ca2+ Influx Channel TRPC3 Protects Secretory Epithelia From Ca2+-Dependent Toxicity

https://doi.org/10.1053/j.gastro.2011.02.052Get rights and content

Background & Aims

Excessive Ca2+ influx mediates many cytotoxic processes, including those associated with autoimmune inflammatory diseases such as acute pancreatitis and Sjögren syndrome. Transient receptor potential (canonical) channel (TRPC) 3 is a major Ca2+ influx channel in pancreatic and salivary gland cells. We investigated whether genetic or pharmacologic inhibition of TRPC3 protects pancreas and salivary glands from Ca2+-dependent damage.

Methods

We developed a Ca2+-dependent model of cell damage for salivary gland acini. Acute pancreatitis was induced by injection of cerulein into wild-type and Trpc3/ mice. Mice were also given the Trpc3-selective inhibitor pyrazole 3 (Pyr3).

Results

Salivary glands and pancreas of Trpc3/ mice were protected from Ca2+-mediated cell toxicity. Analysis of Ca2+ signaling in wild-type and Trpc3/ acini showed that Pyr3 is a highly specific inhibitor of Tprc3; it protected salivary glands and pancreas cells from Ca2+-mediated toxicity by inhibiting the Trpc3-mediated component of Ca2+ influx.

Conclusions

TRPC3-mediated Ca2+ influx mediates damage to pancreas and salivary glands. Pharmacologic inhibition of TRPC3 with the highly selective TRPC3 inhibitor Pyr3 might be developed for treatment of patients with acute pancreatitis and Sjögren syndrome.

Section snippets

Materials and Methods

Detailed methods are given in Supplementary Materials and Methods. Only key methods are described in detail here.

Pyr3 Is a Selective Inhibitor of Trpc3

Previous work indicated that Pyr3 is a selective TRPC3 inhibitor because it did not or poorly inhibited other TRPC and TRP channels.28 However, the specificity of Pyr3 for the native TRPC3 was not determined. We use pancreatic and parotid acini from Trpc3/ mice to test the selectivity of Pyr3. Preliminary experiments showed that maximal inhibition of receptor-stimulated Ca2+ signaling is observed with 3 μmol/L Pyr3, with 10 to 50 μmol/L Pyr3 inhibiting Ca2+ signaling to the same extent as 3

Discussion

The present study examined the potential use of a specific Trpc3 inhibitor in the treatment of the autoimmune inflammatory diseases acute pancreatitis and Sjögren syndrome. The first novel finding of the present study is the importance of Trpc3 for salivary secretion. Salivary secretion is a Ca2+-mediated process,18 and Ca2+ influx is essential to sustain the secretion. Salivary glands express several TRPC channels, including TRPC1, TRPC3, and TRPC6.20 Deletion of Trpc3 in mice reduced salivary

References (43)

Cited by (95)

  • A microRNA checkpoint for Ca<sup>2+</sup> signaling and overload in acute pancreatitis

    2022, Molecular Therapy
    Citation Excerpt :

    In addition, it is of importance to confirm the expression of pancreatic miR-26a in a larger cohort of patients with AP. Each of the key SOCE proteins TRPC3, TRPC6, ORAI1, and STIM1 participate in Ca2+ entry,11–14,62 while SARAF, through interaction with STIM1, mediates Ca2+-dependent channel inactivation.16 Our identification of TRPC6 as a channel regulated by miR-26a, integral to Ca2+ entry in PACs and upregulated in AP, expands the range of Ca2+ channels implicated in AP.

View all citing articles on Scopus

Conflicts of interest The authors disclose no conflicts.

Funding Supported by the Intramural Research Program of the National Institutes of Health National Institute of Dental and Craniofacial Research/Division of Intramural Research (S.M.), grant Z01-ES-101684 (to L.B.), the Science Research Program of the National Research Foundation of Korea, and the Ministry of Education, Science and Technology grants 2011-0001167 and 2010-0000315 (to D.M.S.).

View full text